流通市值:489.59亿 | 总市值:638.82亿 | ||
流通股本:66.79亿 | 总股本:87.15亿 |
报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金 | 96,214,387,663.62 | 78,647,425,517.46 | 54,377,652,490.02 | 28,956,265,552.56 |
收到的税费返还 | 424,582,944.63 | 248,582,780.79 | 179,204,333.84 | 108,739,039.11 |
收到其他与经营活动有关的现金 | 2,403,527,313.95 | 1,408,322,871.11 | 689,259,068.99 | 609,883,544.14 |
经营活动现金流入的其他项目 | 1,094,617,810.46 | 694,506,010.44 | 494,198,336.02 | 229,958,973.82 |
经营活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流入小计 | 100,137,115,732.66 | 80,998,837,179.8 | 55,740,314,228.87 | 29,904,847,109.63 |
购买商品、接受劳务支付的现金 | 83,027,408,387.06 | 74,415,661,747.86 | 51,530,143,164.38 | 33,958,783,596.19 |
支付给职工以及为职工支付的现金 | 4,590,881,023.32 | 3,107,690,885.87 | 2,170,882,404.85 | 1,088,034,458.14 |
支付的各项税费 | 4,427,778,282.15 | 3,837,034,492.75 | 2,822,464,734.04 | 891,464,679.86 |
支付其他与经营活动有关的现金 | 7,227,032,605.84 | 3,918,839,233.55 | 2,280,891,630.68 | 1,362,170,678.87 |
经营活动现金流出的其他项目 | 2,982,028,585.12 | 2,323,044,072.72 | 1,477,071,926.08 | 857,427,514.15 |
经营活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流出小计 | 102,255,128,883.49 | 87,602,270,432.75 | 60,281,453,860.03 | 38,157,880,927.21 |
经营活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
经营活动产生的现金流量净额 | -2,118,013,150.83 | -6,603,433,252.95 | -4,541,139,631.16 | -8,253,033,817.58 |
二、投资活动产生的现金流量: | ||||
收回投资收到的现金 | 1,358,220,000 | 1,121,570,000 | 1,121,570,000 | - |
取得投资收益收到的现金 | 37,103,649.04 | 27,065,551.13 | 205,804 | - |
处置固定资产、无形资产和其他长期资产收回的现金净额 | 2,080,310.27 | 1,231,756.39 | 971,795.32 | 459,064.67 |
收到的其他与投资活动有关的现金 | 25,440,000 | 7,291,900 | 2,291,900 | 2,262,300 |
投资活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流入小计 | 1,422,843,959.31 | 1,157,159,207.52 | 1,125,039,499.32 | 2,721,364.67 |
购建固定资产、无形资产和其他长期资产支付的现金 | 7,745,804,432.16 | 3,776,233,310.94 | 2,331,564,199.4 | 1,117,355,298.96 |
投资支付的现金 | 3,217,038,306.14 | 1,967,331,847.35 | 1,677,187,133.26 | 1,331,640,839.05 |
取得子公司及其他营业单位支付的现金 | 964,829,190.77 | 297,760,769.3 | 20,146,441.42 | 8,594,306.15 |
支付其他与投资活动有关的现金 | - | 1,293,837,691.14 | 400,929,697.99 | 259,276,313.55 |
投资活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流出小计 | 11,927,671,929.07 | 7,335,163,618.73 | 4,429,827,472.07 | 2,716,866,757.71 |
投资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
投资活动产生的现金流量净额 | -10,504,827,969.76 | -6,178,004,411.21 | -3,304,787,972.75 | -2,714,145,393.04 |
三、筹资活动产生的现金流量: | ||||
吸收投资收到的现金 | 442,848,268.54 | 409,223,011.77 | 245,779,455.59 | 103,327,700 |
其中:子公司吸收少数股东投资收到的现金 | 442,848,268.54 | 409,223,011.77 | 245,779,455.59 | 103,327,700 |
取得借款收到的现金 | 24,615,339,330.49 | 14,929,191,608.95 | 8,376,897,066.24 | 3,865,222,094.06 |
收到其他与筹资活动有关的现金 | 623,192,809.32 | 2,156,889,452.65 | 295,804,125.27 | 82,392,208.62 |
筹资活动现金流入平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流入小计 | 25,681,380,408.35 | 17,495,304,073.37 | 8,918,480,647.1 | 4,050,942,002.68 |
偿还债务支付的现金 | 13,213,927,182.28 | 6,752,281,942.28 | 4,501,566,447.93 | 1,096,240,343.2 |
分配股利、利润或偿付利息支付的现金 | 7,053,138,485.41 | 5,781,378,135.03 | 4,715,108,142.28 | 819,618,484.52 |
其中:子公司支付给少数股东的股利、利润 | 40,977,149.88 | 40,083,186.79 | 33,343,561.43 | 774,000 |
支付其他与筹资活动有关的现金 | 2,657,908,788.6 | 2,595,867,296.52 | 1,456,049,347.78 | 1,028,555,518.19 |
筹资活动现金流出平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流出小计 | 22,924,974,456.29 | 15,129,527,373.83 | 10,672,723,937.99 | 2,944,414,345.91 |
筹资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
筹资活动产生的现金流量净额 | 2,756,405,952.06 | 2,365,776,699.54 | -1,754,243,290.89 | 1,106,527,656.77 |
四、汇率变动对现金及现金等价物的影响 | -19,323,589.17 | 3,166,848.68 | -21,102,100.88 | -19,805,587.36 |
现金及现金等价物净增加额平衡项目 | 0 | 0 | 0 | 0 |
五、现金及现金等价物净增加额 | -9,885,758,757.7 | -10,412,494,115.94 | -9,621,272,995.68 | -9,880,457,141.21 |
加:期初现金及现金等价物余额 | 31,189,809,753.76 | 31,189,809,753.76 | 31,189,809,753.76 | 31,189,809,753.76 |
期末现金及现金等价物余额平衡项目 | 0 | 0 | 0 | 0 |
期末现金及现金等价物余额 | 21,304,050,996.06 | 20,777,315,637.82 | 21,568,536,758.08 | 21,309,352,612.55 |
补充资料: | ||||
净利润 | 9,037,378,965.75 | - | 5,718,031,790.35 | - |
资产减值准备 | 349,647,131.02 | - | 74,377,170.22 | - |
固定资产和投资性房地产折旧 | 688,125,459.1 | - | 271,649,449.98 | - |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 688,125,459.1 | - | 271,649,449.98 | - |
无形资产摊销 | 693,549,800.71 | - | 338,254,888.42 | - |
长期待摊费用摊销 | 521,697,633.82 | - | 206,345,876.73 | - |
处置固定资产、无形资产和其他长期资产的损失 | 4,142,444.92 | - | -74,522.32 | - |
固定资产报废损失 | 3,478,948.15 | - | -1,243,178.27 | - |
公允价值变动损失 | 2,640,318.97 | - | 93,033.82 | - |
财务费用 | 2,806,364,286.81 | - | 1,306,745,601.65 | - |
投资损失 | -193,315,083.87 | - | -65,142,971.7 | - |
递延所得税 | 8,909,365.58 | - | -6,184,300.57 | - |
其中:递延所得税资产减少 | -106,334,874.84 | - | -67,510,445.6 | - |
递延所得税负债增加 | 115,244,240.42 | - | 61,326,145.03 | - |
存货的减少 | -503,083,021.09 | - | -1,082,354,925.45 | - |
经营性应收项目的减少 | -23,196,735,241.6 | - | -8,357,829,132.34 | - |
经营性应付项目的增加 | 5,367,676,831.49 | - | 1,507,150,741.52 | - |
其他 | 81,205,701.9 | - | 293,743,148.01 | - |
现金的期末余额 | 21,304,050,996.06 | - | 21,568,536,758.08 | - |
减:现金的期初余额 | 31,189,809,753.76 | - | 31,189,809,753.76 | - |
公告日期 | 2024-04-23 | 2023-10-31 | 2023-08-31 | 2023-04-29 |
审计意见(境内) | 标准无保留意见 |